Regulus Therapeutics Inc. (RGLS)

AI Score

Unlock

1.81

-0.15 (-7.65%)

At close: Apr 03, 2025, 3:59 PM

1.80

-0.55%

After-hours: Apr 03, 2025, 04:42 PM EDT

Regulus Therapeutics Balance Sheet Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Cash & Equivalents	38.53M	23.77M	24.23M	60.38M	31.09M	34.12M	13.94M	13.52M	76.11M	115.32M	37.33M	114M	40.55M	9.18M	21.27M
Short-Term Investments	37.25M	n/a	14.93M	n/a	n/a	n/a	n/a	46.55M	61.17M	98.1M	122.42M	96.2M	57.55M	28.97M	33.52M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	291K	277K	487K	326K	590K	342K	344K	1.81M	987K	125K	125K	125K
Receivables	n/a	n/a	n/a	n/a	503K	1.14M	26K	373K	1.66M	10.02M	274K	79K	n/a	n/a	n/a
Inventory	n/a	3.01M	3.01K	3.01K	3.31M	3.92M	4.19M	4.78M	5.55M	-10.02M	n/a	-79K	n/a	n/a	n/a
Other Current Assets	6.57M	62K	62K	62K	n/a	1.22M	1.14M	1.51M	n/a	6.8M	742K	n/a	829K	n/a	386K
Total Current Assets	82.34M	28.18M	44.08M	65.23M	36.73M	40.41M	19.3M	66.74M	87.47M	134.26M	164.95M	117.18M	98.93M	38.67M	55.17M
Property-Plant & Equipment	1.81M	2.54M	2.58M	2.85M	472K	921K	7.81M	9.71M	11.83M	5.4M	3.57M	3.77M	3.31M	3.11M	3.46M
Goodwill & Intangibles	25K	33K	62K	83K	125K	266K	500K	775K	1.01M	1.08M	1.15M	1.13M	1.15M	980K	945K
Total Long-Term Assets	1.84M	2.57M	2.64M	3.22M	874K	1.67M	8.63M	11.07M	13.19M	6.83M	6.53M	5.88M	4.59M	4.21M	4.53M
Total Assets	84.18M	30.75M	46.72M	68.45M	37.6M	42.08M	27.93M	77.81M	100.66M	141.08M	171.48M	123.06M	103.52M	42.88M	59.7M
Account Payables	947K	204K	175K	285K	535K	1.32M	1.71M	5.74M	5.84M	2.72M	2.19M	1.17M	311K	501K	1.29M
Deferred Revenue	n/a	n/a	n/a	-589K	3.42M	6K	2.57M	72K	72K	1.19M	3.1M	4.89M	10.45M	10.73M	10.73M
Short-Term Debt	n/a	1.33M	4.51M	n/a	4.65M	14.63M	16.57M	19.86M	n/a	n/a	23.4M	n/a	n/a	n/a	412K
Other Current Liabilities	6.55M	5.36M	2.55M	1.29M	4.65M	4.72M	4.18M	4.94M	5.58M	6.33M	4.4M	3.01M	658K	360K	1.09M
Total Current Liabilities	7.5M	8.51M	11.66M	5.23M	11.58M	21.6M	26.65M	32.6M	13.73M	11.44M	8.7M	5.48M	12.77M	12.85M	14.73M
Long-Term Debt	274K	n/a	n/a	4.67M	n/a	n/a	n/a	n/a	19.8M	n/a	n/a	11.28M	10.13M	10M	10.81M
Other Long-Term Liabilities	n/a	n/a	n/a	1.18M	n/a	468K	7.13M	8.07M	10.98M	2.31M	1.02M	1.46M	767K	44.1M	957K
Total Long-Term Liabilities	274K	1.05M	1.77M	8.27M	n/a	468K	7.13M	9.99M	30.85M	5.57M	30.77M	24.13M	28.66M	71.53M	36.98M
Total Liabilities	7.77M	9.56M	13.43M	13.5M	11.58M	22.07M	33.78M	42.59M	44.59M	17M	39.47M	29.61M	41.42M	84.38M	51.71M
Total Debt	274K	2.39M	6.28M	7.09M	4.65M	14.63M	16.57M	19.86M	19.8M	n/a	23.4M	11.28M	10.13M	10.81M	11.23M
Common Stock	66K	20K	17K	146K	67K	21K	9K	104K	53K	53K	49K	42K	36K	n/a	n/a
Retained Earnings	-559.57M	-513.21M	-483.18M	-454.85M	-427.05M	-411.31M	-392.72M	-345.86M	-273.35M	-191.51M	-135.77M	-79.09M	-60.42M	-43.01M	-35.41M
Comprehensive Income	50K	n/a	-12K	n/a	n/a	n/a	-9.89M	-134K	-123K	-133K	-197K	-16K	-52K	-67K	13K
Shareholders Equity	76.41M	21.19M	33.29M	54.96M	26.03M	20.02M	-5.85M	35.22M	56.08M	124.08M	132.01M	93.46M	62.09M	-41.49M	8M
Total Investments	37.25M	n/a	14.93M	n/a	n/a	n/a	n/a	46.55M	61.17M	98.1M	122.42M	96.2M	57.55M	28.97M	33.52M